-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Maintains Outperform on Insulet, Lowers Price Target to $175

Benzinga·08/06/2026 16:46:06
Listen to the news
Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $200 to $175.